-Tai-Xiang Lu Researcher Activity Profile

Research Author Detailed Information 

Tai-Xiang Lu Publication Rate By Year

Tai-Xiang Lu has published 1 paper(s) in 2002, 7 paper(s) in 2006, 18 paper(s) in 2007, for a total of 26 research publications in total.

Tai-Xiang Tx Lu Author Information

LAST NAME: lu

FIRST NAME: Tai-Xiang

INITIALS: tx

AFFILIATION:

Papers

Tai-Xiang Lu's Publication Record

1. [Weekly paclitaxel with concurrent intensity-modulated radiotherapy for nasopharyngeal carcinoma: outcomes of a tolerance trial] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
2. [Treatment of primary trauma in the brainstem: analysis of 126 cases] Year Published: 2002
Department of Neurosurgery, People's Hospital of Xinhui City, Xinhui 529100, China.
3. [Evaluation of CT, MRI and PET-CT in detecting retropharyngeal lymph node metastasis in nasopharyngeal carcinoma] Year Published: 2006
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
4. [Clinical characters of aged nasopharyngeal carcinoma patients] Year Published: 2006
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
5. [Diagnosis of recurrent or residual nasopharyngeal carcinomas in the skull base area with F-18-fluoro-deoxyglucose positron emission tomography] Year Published: 2006
The Second Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510120, China.
6. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer] Year Published: 2006
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
7. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases] Year Published: 2006
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
8. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage] Year Published: 2006
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
9. [Radiation-induced temporomandibular joint damage in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
10. [Influences of magnetic resonance imaging on the staging system of nasopharyngeal carcinoma] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, PR China.
11. [Design planning target volumes (PTVs) in intensity-modulated radiotherapy for nasopharyngeal carcinoma] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, PR China.
12. [Prospective study on long-term efficacy of external plus intracavitary radiotherapy on stage I-II nasopharyngeal carcinoma] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, PR China. cxpgz@tom.com
13. [Clinical study on radiotherapy-related typing of nasopharyngeal carcinoma] Year Published: 2007
Department of Radiation Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, China.
14. [Sparing normal oral tissues with individual dental stent in radiotherapy for primary nasopharyngeal carcinoma patients] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, PR China.
15. [Clinical Staging of Nasopharyngeal Carcinoma Based on MRI:Suggestions for Improving the Chinese '92 Staging System.] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
16. [Correlation of DNA ploidy in fresh tumor tissues to prognosis of nasopharyngeal carcinoma] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, PR China.
17. [Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma] Year Published: 2007
Department of Radiation Oncology, Cancer Center of Sun Yat-sen University, Guangzhou 510060, China. bedgoody@pub.guangzhou.gd.cn
18. [Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma] Year Published: 2007
Department of Radiation Oncology, Cancer Hospital (Institute), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
19. [Phase II clinical trial of h-R3 combined radiotherapy for locoregionally advanced nasopharyngeal carcinoma] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, PR China.
20. [Clinical Staging of Nasopharyngeal Carcinoma Based on MRI:Suggestions for Improving the Chinese '92 Staging System.] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
21. [Correlation of DNA ploidy in fresh tumor tissues to prognosis of nasopharyngeal carcinoma] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, PR China.
22. IL-13 involvement in eosinophilic esophagitis: Transcriptome analysis and reversibility with glucocorticoids. Year Published: 2007
Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
23. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. Year Published: 2007
Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.
24. [Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system] Year Published: 2007
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
25. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer] Year Published: 2006
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
26. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. Year Published: 2007
Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.